Literature DB >> 11450880

Current treatment of high grade osteosarcoma of the extremity: review.

G Bacci1, S Lari.   

Abstract

The authors review their lengthy experience in treating high grade osteosarcoma of the extremity. During the past 20 years many advances have been made in treating high grade osteosarcoma of the extremity. Twenty years ago, in spite of amputation, most patients with this tumor died, whereas today most are cured and amputation is avoided. These advances are mainly due to the development of effective adjuvant and neoadjuvant chemotherapy regimens. This review reports on the progress and controversies in the treatment of osteosarcoma.

Entities:  

Mesh:

Year:  2001        PMID: 11450880     DOI: 10.1179/joc.2001.13.3.235

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  11 in total

1.  A jeep trip with young adult cancer survivors: lessons to be learned.

Authors:  P Elad; Y Yagil; L Cohen; I Meller
Journal:  Support Care Cancer       Date:  2003-01-25       Impact factor: 3.603

Review 2.  Clinical applications of molecular imaging in sarcoma evaluation.

Authors:  Rodney J Hicks; Guy C Toner; Peter F M Choong
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909

3.  Expression and significance of glucose-regulated protein 78 in human osteosarcoma.

Authors:  Yongkui Zhang; Nianhu Li; Dongli Wang; Yiqiang Chen; Gang Li
Journal:  Oncol Lett       Date:  2015-03-12       Impact factor: 2.967

4.  Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?

Authors:  Zhengfu Fan; Shreyaskumar Patel; Valerae O Lewis; B Ashleigh Guadagnolo; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2015-07-22       Impact factor: 4.176

5.  Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.

Authors:  Youssef Erfanian; Johannes Grueneisen; Julian Kirchner; Axel Wetter; Lars Erik Podleska; Sebastian Bauer; Thorsten Poeppel; Michael Forsting; Ken Herrmann; Lale Umutlu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-31       Impact factor: 9.236

Review 6.  The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.

Authors:  Isabelle Corre; Franck Verrecchia; Vincent Crenn; Francoise Redini; Valérie Trichet
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

7.  The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence.

Authors:  Jianping Zhang; Na Li; Siyu Lu; Yanling Chen; Lequn Shan; Xingcheng Zhao; Yongqing Xu
Journal:  J Orthop Surg Res       Date:  2021-03-29       Impact factor: 2.359

8.  Establishment of a new human osteosarcoma cell line, UTOS-1: cytogenetic characterization by array comparative genomic hybridization.

Authors:  Taketoshi Yasuda; Masahiko Kanamori; Shigeharu Nogami; Takeshi Hori; Takeshi Oya; Kayo Suzuki; Tomoatsu Kimura
Journal:  J Exp Clin Cancer Res       Date:  2009-02-25

9.  Extracapsular wide resection of a femoral neck osteosarcoma and its reconstruction using a pasteurized autograft-prosthesis composite: A case report.

Authors:  Taketoshi Yasuda; Takeshi Hori; Kayo Suzuki; Jun Hachinoda; Isao Matsushita; Yoshiaki Ito; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2013-07-31       Impact factor: 2.967

10.  USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis.

Authors:  Guojun Wei; Tianwei Zhang; Zongguang Li; Naichun Yu; Xiang Xue; Daguo Zhou; Yongjie Chen; Linlin Zhang; Xiaoli Yao; Guangrong Ji
Journal:  Aging (Albany NY)       Date:  2020-04-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.